Chun Guo

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

E. Rappaport, J. Maris, Y. Mossé, 2003, Cancer Research.

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

D. Stram, J. Maris, K. Matthay, 1999, Oncogene.

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

M. Urbanek, T. Rebbeck, J. Maris, 2002, Cancer research.

Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

H. Mo, D. Luo, Yu-Yun Du, 2021, Cancer research and treatment : official journal of Korean Cancer Association.

No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.

A. Look, J. Maris, P. White, 2002, Cancer Research.

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

D. Stram, J. Maris, K. Matthay, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of genomic imprinting at 1p35-36 in neuroblastoma.

J. Maris, P. White, M. Hogarty, 2001, Medical and pediatric oncology.

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

D. Stram, J. Maris, K. Matthay, 2001, Medical and pediatric oncology.